Shares of CVS Caremark are climbing after the drugstore and pharmacy chain reported fourth-quarter earnings that climbed more than 12%. The company said results were boosted by pharmacy revenue at its established drugstores, which grew 6.8% during the quarter. CVS managed to fill 3.8% more prescriptions and sell more generic drugs despite processing fewer network claims and seeing a decline in store traffic. Overall, revenue in the period rose 4.6% to about $32.8 billion, beating analyst forecasts of about $32.6 billion, according to Thomson Reuters.

Brittany joined TheStreet.com TV in November 2006 after completing a degree in Journalism and Media Studies at Rutgers College. Previously, Brittany interned at the local ABC affiliate in New York City WABC-TV 7 where she helped research and produce On Your Side, a popular consumer advocacy segment.

If you liked this article you might like

Jim Cramer: You Have to Decide If You Want to Profit From This Moment

Jim Cramer: You Have to Decide If You Want to Profit From This Moment

It's Dumb to Think Amazon Will Be Able to Skirt Regulators Forever

It's Dumb to Think Amazon Will Be Able to Skirt Regulators Forever

Walmart Sinks Dow; Albertsons to Fight Off Grocery Struggles With Rite Aid-ICYMI

Walmart Sinks Dow; Albertsons to Fight Off Grocery Struggles With Rite Aid-ICYMI

Rite Aid Pops After Albertsons Plans to Buy Part of Drugstore Chain

Rite Aid Pops After Albertsons Plans to Buy Part of Drugstore Chain

Goldman Bankers (Mostly) Upbeat on Tech M&A and IPO Trends

Goldman Bankers (Mostly) Upbeat on Tech M&A and IPO Trends